BRANDL TALOS advises Sportradar on the formation of a joint venture with Ringier AG

Press release • Venture Capital & Start Ups from Thomas Talos, Stephan Strass

BRANDL TALOS advised Sportradar Group AG (NASDAQ: SRAD), a leading global provider of sports data and content, on the formation of a joint venture with Ringier AG, a Swiss technology and media company.

Closing of the transaction is subject of certain customary conditions and is expected to occur shortly.

The joint venture aims at bringing sports closer to fans in Africa, a dynamic and emerging region in the global sports industry. It combines Ringier’s media expertise with Sportradar’s sports data and product portfolio and builds on a long-standing relationship of collaboration and innovation between the two Swiss-based companies. In the joint venture, Sportradar and Ringier are backing the pan-African media company Pulse, already part of the Ringier portfolio.

The BRANDL TALOS deal team consisted of Thomas Talos, Stephan Strass, Daniel Schmidt and Céline Dobnikar.

Bowmans advised on aspects of the relevant African jurisdictions and Bär & Karrer AG provided advice on Swiss-law aspects. Ringier was advised by Webber Wentzel.

The team

Thomas Talos

Array
(
    [0] => WP_Term Object
        (
            [term_id] => 5
            [name] => Attorney at Law
            [slug] => attorney-at-law
            [term_group] => 0
            [term_taxonomy_id] => 5
            [taxonomy] => category
            [description] => 
            [parent] => 0
            [count] => 17
            [filter] => raw
        )

    [1] => WP_Term Object
        (
            [term_id] => 4
            [name] => Partner
            [slug] => partner
            [term_group] => 0
            [term_taxonomy_id] => 4
            [taxonomy] => category
            [description] => Partner
            [parent] => 0
            [count] => 11
            [filter] => raw
        )

)

Partner / Capital Markets, Corporate Law & Transactions, Gaming & Entertainment

Thomas founded the firm in 2000 together with Ernst Brandl. He is co-publisher of the commentary on the EU Merger Act and (co-)author of numerous publications.

University of Vienna, Faculty of Law (Mag. iur. 1991, Dr. iur. 1994)
University of Virginia, School of Law (LL.M. 1994)

Stephan Strass

Array
(
    [0] => WP_Term Object
        (
            [term_id] => 5
            [name] => Attorney at Law
            [slug] => attorney-at-law
            [term_group] => 0
            [term_taxonomy_id] => 5
            [taxonomy] => category
            [description] => 
            [parent] => 0
            [count] => 17
            [filter] => raw
        )

    [1] => WP_Term Object
        (
            [term_id] => 4
            [name] => Partner
            [slug] => partner
            [term_group] => 0
            [term_taxonomy_id] => 4
            [taxonomy] => category
            [description] => Partner
            [parent] => 0
            [count] => 11
            [filter] => raw
        )

)

Partner / Venture Capital & Start Ups, Corporate Law & Transactions, BioTech & Lifescience

Stephan advises innovative start-ups, institutional and strategic investors and other companies on acquisitions, financing rounds, joint ventures and exit transactions with a focus on highly regulated industries such as life sciences, biotech and leisure & entertainment. He further specializes in commercial transactions in the life science and biotech sector, including university spin-offs, strategic collaborations, patent and technology license agreements and IP purchase transactions.

He has co-authored commentaries on the EU Merger Act and the Investment Fund Act, and is the author of many academic publications.

University of Vienna, Faculty of Law (Mag. iur. 2015)
Harvard Law School, Master of Laws (LL.M. 2019)

Latest insights into
Venture Capital & Start Ups

BRANDL TALOS advises Graph Therapeutics on USD 3.1 million pre-seed financing round

Press release • Venture Capital & Start Ups from Stephan Strass, Lara Präthaler

Graph Therapeutics, a next-generation techbio company, has successfully closed a USD 3.1 million pre-seed financing round. The round is led by Squareone and Merantix Capital, with participation from NAVEC Investment Management and strategic angel investors such as the Atomico Angel Program.

BRANDL TALOS advised Springtime and its Founders on growth equity investment from Scottish Equity Partners

Press release • Venture Capital & Start Ups from Roman Rericha, Adrian Zuschmann, Joseph Gstöttner, Daniel Habich

Springtime Technologies, a leading provider of AI-driven accounts payable automation software, has received a significant growth equity investment from Scottish Equity Partners (SEP), one of Europe's most respected growth equity firms. This strategic partnership marks an exciting new chapter in Springtime's 20-year journey of empowering enterprises with innovative solutions for financial operations.

BRANDL TALOS advises Sportradar on $ 30 million acquisition of XLMedia PLC’s North American business

Press release • Venture Capital & Start Ups from Thomas Talos, Stephan Strass

BRANDL TALOS advised its longstanding client Sportradar on the acquisition of the key assets of XLMedia PLC’s North American business.